U.S. imports of Immunological Products in Measured Doses or for Retail Sale (HS 300215) totaled $3.7B in August 2026, imported from 42 countries.
Importers of Immunological Products in Measured Doses or for Retail Sale paid $608K in duties in August 2026, an average duty rate of 0.02% — duty actually collected as a share of the imports that cleared customs, not the published tariff schedule. Immunological Products in Measured Doses or for Retail Sale imports of $3.7B in August 2026 ran 21% below the year-to-date monthly average of $4.6B.
Last updated: August 2026 dataRetail-packaged and measured-dose immunological products — including monoclonal-antibody-based therapeutics — represent some of the highest-value pharmaceutical imports entering the US market. Germany and Ireland are the dominant suppliers, a pattern driven by the large number of FDA-approved biologics manufactured at European facilities. The US tariff schedule distinguishes monoclonal-antibody-containing products (3002150011) from other retail immunological preparations (3002150091 and 3002150100), and each line may carry different FDA review requirements at entry. Importers should verify that the foreign establishment is registered with FDA and that the specific product holds the appropriate approval or authorization before shipment.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
2.7K import shipments a month
The HS structure separates retail/measured-dose presentations (heading 300215) from bulk non-retail forms (300214) because packaging and dosage form affect both the regulatory pathway and the commercial distribution channel. Measured-dose products are typically finished drug products subject to full FDA drug or biologics approval, while bulk forms may enter under different import authorization frameworks.
The importer must confirm the product has an active FDA Biologics License Application (BLA) or New Drug Application (NDA), that the foreign manufacturer is registered with FDA, and that the shipment is accompanied by a certificate of analysis and proper labeling. FDA may detain shipments that lack adequate documentation. Engaging a licensed customs broker with pharmaceutical experience is advisable given the complexity of admissibility review.
ImportsExports
Imports
$3.7BYoY · free account
Exports
$1.7BYoY · free account
12-mo low · imports
Low · free accountOver the twelve months to August 2026, the U.S. imported $62.1B of Immunological Products in Measured Doses or for Retail Sale and exported $25.5B.
Through August 2026. Source: U.S. Census Bureau.
Imports · August 2026
origin
customs district
destination
entry
rate provision · imports
99.5% enters free of duty; duty collected equals 0.02% of imports for consumption.
HS10 import codes under this HS6 parent, each with its own page. Source: U.S. Harmonized Tariff Schedule.
| Code | Description | Imports for consumption | Average duty rate | Dutiable Share | Duty Collected |
|---|---|---|---|---|---|
| 3002150011 | Immunological Prdcts, Contain Monoclonal Antibodies | $3.3B | 0.01% | 0.09% | $455K |
| 3002150091 | Immunological Products for Retail Sale, NESOI | $381.6M | 0.04% | 0.21% | $153K |
HS10 export codes under this HS6 parent, each with its own page. Source: U.S. Schedule B export classification.
| Code | Description | Export Value |
|---|---|---|
| 3002150100 | Immunological Products, For Retail Sale | $1.7B |
Import lines come from the U.S. Harmonized Tariff Schedule and export lines from Schedule B. The two are numbered by different agencies, so the same 10-digit code can appear in both tables describing a different product.
Subheading 1 of 10 in heading 3002
Subheading 300215 · $3.7B of $5.8B
Trade Directory
List your company under HS 300215 — Immunological Products in Measured Doses or for Retail Sale, so the companies trading it can find you. Be the first supplier listed.